Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention ; volume:2 ; number:3 ; day:31 ; month:5 ; year:2001 ; pages:1-12 ; date:6.2001
Trials ; 2, Heft 3 (31.5.2001), 1-12, 6.2001
- Urheber
-
ten Berg, Jurriën M.
- Beteiligte Personen und Organisationen
-
Plokker, HW Thijs
Verheugt, Freek WA
SpringerLink (Online service)
- DOI
-
10.1186/cvm-2-3-129
- URN
-
urn:nbn:de:1111-2016050214972
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- ten Berg, Jurriën M.
- Plokker, HW Thijs
- Verheugt, Freek WA
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
Meta-analysis of Unguided De-escalation of Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
Meta-analysis of Unguided De-escalation of Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials